|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Allvivo Inc., of Lake Forest, Calif., received a Small Business Innovation Research grant from the National Science Foundation to develop its biomimetic surface technology. The technology binds selected proteins to plastic surfaces but preserves the proteins' function while preventing other proteins or cells from adhering to the surface. The technology can be used to examine cell behavior, develop medical devices and in tissue engineering and cell therapy applications.
Angiotech Pharmaceuticals Inc., of Vancouver, British Columbia, began a Phase II study of Paxceed (micellar paclitaxel for injection) to treat patients with rheumatoid arthritis. The open-label, ...
Related newspaper, magazine, and journal articles:
|
|
Article: British Columbia Court of Appeal rules that, where ...
International Law Update;
July 1, 2005 ;
700+ words
... ... defendant) in the British Columbia Supreme Court ... plaintiff in a New York federal court ... dismissal of the New York action on jurisdictional ... declaration that the British Columbia Supreme Court ... dispute. The New York court denied plaintiff ...
|
|